1. Home
  2. LEU vs ADRX Comparison

LEU vs ADRX Comparison

Compare LEU & ADRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centrus Energy Corp.

LEU

Centrus Energy Corp.

N/A

Current Price

$81.73

Market Cap

1.9B

Sector

Industrials

ML Signal

N/A

Logo ADARx Pharmaceuticals Inc. Common Stock

ADRX

ADARx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$12.91

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEU
ADRX
Founded
1998
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1998
2026

Fundamental Metrics

Financial Performance
Metric
LEU
ADRX
Price
$81.73
$12.91
Analyst Decision
Buy
Strong Buy
Analyst Count
21
5
Target Price
★ $180.00
$33.75
AVG Volume (30 Days)
★ 719.9K
416.1K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.63
N/A
Revenue
★ $193,000,000.00
N/A
Revenue This Year
$6.14
$69.35
Revenue Next Year
$7.34
$582.60
P/E Ratio
$34.09
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$84.86
$12.50
52 Week High
$345.60
$19.57

Technical Indicators

Market Signals
Indicator
LEU
ADRX
Relative Strength Index (RSI) 32.23 35.40
Support Level N/A $12.50
Resistance Level $117.45 $18.94
Average True Range (ATR) 8.27 1.89
MACD -0.54 -0.07
Stochastic Oscillator 0.79 8.05

Price Performance

Historical Comparison
LEU
ADRX

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

About ADRX ADARx Pharmaceuticals Inc. Common Stock

Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.

Share on Social Networks: